Astera Labs (NASDAQ:ALAB) Sets New 1-Year High – What’s Next?

Astera Labs, Inc. (NASDAQ:ALAB) reached a new 52-week high during trading on Friday . The company traded as high as $377.00 and last traded at $387.4730, with a volume of 204486 shares traded. The stock had previously closed at $367.47.

Analysts Set New Price Targets

Several analysts have commented on the stock. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Susquehanna upped their price target on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Evercore restated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Royal Bank Of Canada upped their target price on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, May 6th. Finally, Roth Mkm reiterated a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Trading Up 2.1%

The company has a 50 day moving average of $231.95 and a 200-day moving average of $177.61. The firm has a market capitalization of $64.30 billion, a P/E ratio of 253.47, a P/E/G ratio of 4.38 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the previous year, the business posted $0.33 earnings per share. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other news, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction on Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This represents a 7.39% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the sale, the director owned 319,863 shares in the company, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,321,256 shares of company stock valued at $480,893,146 over the last three months. 10.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently modified their holdings of the business. Atreides Management LP boosted its holdings in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares in the last quarter. Vanguard Group Inc. raised its position in Astera Labs by 14.1% in the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after buying an additional 1,693,918 shares during the last quarter. Amundi lifted its stake in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC purchased a new position in Astera Labs in the third quarter worth $209,599,000. Finally, BNP Paribas Financial Markets grew its stake in Astera Labs by 577.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after purchasing an additional 960,899 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.